lakers_w, nevertheless Lilly is advertising Jardiance very often in tv ads now. These warnings are not mentioned in the tv ads.
dekine1840, if one is a market maker who has clients who are short, it's what you do to help the client cover.
metalman_7911978, I saw the 198K puts trade for Oct $8, but 194,500 in two blocks traded for exactly $1.00 (about 11:20 am) when the bid/ask was something like .97/1.02. It looked to me it could have been a trader covering (selling as you wrote) a long put, because there was an open interest of about 213K. That's about 19 million shares that were short that some market maker covered. I assume the trader had a hefty profit he wanted to salt away.
pkgossett, it is Jewish new year, and you may have heard sell on Rosh Hashanah and buy on Yom Kippur. The shorts could play games Monday and during the week seeking advantage with assumed lower volume.
doctor.stockpicker, you are an Afrezza prescribing doctor in Oklahoma, but on Sam Finta's blog list of Afrezza prescribing docs there is no practice listed from Oklahoma. He has a lot of docs listed already all over the USA, and your practice can help with the people in Oklahoma who are looking for Afrezza.
avi8torslc, you know, you indicated in late July, as I recall, you had removed your MNKD shares from the Fido loan facility. I remember reading that. Why and when did you reup into their stock loan program?
The real doctor.stockpicker uses a dot not an underscore.
cedafuntennis, did you notice that was from the year 2005 completion. Where is the drug? Ten years should be enough time after the trial was completed.
I contacted Sanofi directly, and I asked whether Sanofi has any other inhalable drug than Afrezza. The answer I was given is Afrezza is the only inhalable drug Sanofi has. He said MNKD is developing other inhalable drugs.
I contacted Sanofi. Sanofi's only inhalable drug is Afrezza.
penny222dollar, does this change the date BAC has to return the 9 million shares MNKD loaned BAC?
blindhog1, I seem to recall you may be in some FDA trial that goes for years -- something about heart drug or something like that. Is that right? I will make the (maybe incorrect) assumption you were taking diabetic drugs before you were selected for this FDA trial. Did the FDA trial drug and procedure have any impact on your A1C at any time? Apologize if I have this FDA stuff wrong.
lakers_w, in the 8-K I see the $32.05M note matures on September 30, 2015, but the deadline for any note for stock exchange must be done between August 13,2015 and September 24, 2015.
mnholdem, yes, I understand and understood the agreement, I thought and still think. This quote from Matt Pfeffer from the earnings call is what I still have no explanation for: "Since these shares would have to be repurchased in the open market after maturity and would be returned to us,...." Thanks for posting the 2010 share lending agreement, and from the text I see nothing that would support Matt's quote above. It seems to me BAC could have had the 9M shares anytime ready to return, and there is no obligation for BAC to repurchase the 9M shares in the open market AFTER MATURITY. That quote from Matt remains a mystery to me. I have a call into Matt from yesterday to get a clarification of the statement.
alohazabel, that is what I thought, but I took Matt Pfeffer's comment in the earnings call yesterday to mean BAC had to buy the shares after maturity of the agreement. I posted this about 10 or 20 minutes ago. You can read the quote there, or you will find it in the transcript. If BAC has to buy after maturity, they are going to have to pay up, and the other shorts will be in there likely having to buy along with them.
itellthefuture777, you are a bad reader of hands. I am asking a question, and I am a long term holder of MNKD. You must have been talking at the poker table while others were playing their hands. Read the transcript, and I provided the relevant portion that I seek an answer to. You clearly do not have the answer.
I was not aware the Bank of America would be legally obligated to cover any of the 9 million shorts (repurchase) it may have AFTER maturity of its agreement with MNKD. This below is a direct quote from Matt's earnings call with analysts and investors on August 10, 2015. I always assumed Bank of America could do anything it wanted to do anytime as long as it returns the 9 million shares by the deadline. Does this language below in quotes sound like what is in the legal agreement with Bank of America?
Matt Pfeffer said,
"And finally, we wanted to be sure that the final terms enabled the old notes to go completely away so that MannKind would be certain to get back the 9 million shares linked to the underwriter in the previous transaction."
"Since these shares would have to be repurchased in the open market after maturity and would be returned to us, removing them from circulation, we like to think that any shares we ultimately issued as being net of these shares coming back."
itellthefuture777, they are giving it away in Africa and elsewhere. What is your projection for a market dollar amount for inhaled oxytocin? I assume it is almost nothing at this time.